Updates on lung neuroendocrine neoplasm classification

G Vocino Trucco, L Righi, M Volante… - Histopathology, 2024 - Wiley Online Library
Lung neuroendocrine neoplasms (NENs) are a heterogeneous group of pulmonary
neoplasms showing different morphological patterns and clinical and biological …

Spotlight on small-cell lung cancer and other lung neuroendocrine neoplasms

L Fernandez-Cuesta, A Sexton-Oates… - American Society of …, 2023 - ascopubs.org
Lung neuroendocrine neoplasms (NENs) encompass a spectrum of neoplasms that are
subdivided into the well-differentiated neuroendocrine tumors comprising the low-and …

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure-and combined-small cell lung cancer in mice

SH Hamad, SA Montgomery, JM Simon, BM Bowman… - Oncogene, 2022 - nature.com
Studies have shown that Nrf2 E79Q/+ is one of the most common mutations found in human
tumors. To elucidate how this genetic change contributes to lung cancer, we compared lung …

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms

N Alcala, C Voegele, L Mangiante… - …, 2024 - academic.oup.com
Background Organoids are 3-dimensional experimental models that summarize the
anatomical and functional structure of an organ. Although a promising experimental model …

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

S Mastoraki, I Balgkouranidou, E Tsaroucha… - Molecular …, 2021 - Wiley Online Library
MLL3 histone methyltransferase, encoded by the KMT2C gene, is a tumor suppressor that
has an essential role in cell‐type‐specific gene expression. We evaluated the prognostic …

[HTML][HTML] An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms

G Pelosi, V Melocchi, E Dama, P Hofman… - Experimental and …, 2024 - Elsevier
Little is known as to whether there may be any pathogenetic link between pulmonary
carcinoids and neuroendocrine carcinomas (NECs). A gene signature we previously found …

Bronchial carcinoids: from molecular background to treatment approach

M Araujo-Castro, E Pascual-Corrales, J Molina-Cerrillo… - Cancers, 2022 - mdpi.com
Simple Summary Bronchial carcinoids (BCs) are uncommon and usually slow growing
neuroendocrine epithelial malignancies that represent less than 2% of all lung cancers …

Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma

H Gujar, A Mehta, HT Li, YC Tsai, X Qiu… - Genome Medicine, 2021 - Springer
Background Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer with limited
treatment possibilities. Merkel cell tumors display with neuroendocrine features and Merkel …

Morphologic and molecular heterogeneity of cervical neuroendocrine neoplasia: A report of 14 cases

Z Ordulu, M Mino-Kenudson, RH Young… - The American journal …, 2022 - journals.lww.com
Neuroendocrine neoplasms (NENs) of the cervix are rare aggressive tumors associated with
poor prognosis and only limited treatment options. Although there is some literature on …

Genome methylation accurately predicts neuroendocrine tumor origin: an online tool

WM Hackeng, KMA Dreijerink, WWJ de Leng… - Clinical Cancer …, 2021 - AACR
Purpose: The primary origin of neuroendocrine tumor metastases can be difficult to
determine by histopathology alone, but is critical for therapeutic decision making. DNA …